{"id":"https://openalex.org/W1976362013","doi":"https://doi.org/10.2174/157488409787236047","title":"Evaluation of Human Plasma Protein Binding of Trabectedin (Yondelis\u2122, ET-743)","display_name":"Evaluation of Human Plasma Protein Binding of Trabectedin (Yondelis\u2122, ET-743)","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W1976362013","doi":"https://doi.org/10.2174/157488409787236047","mag":"1976362013","pmid":"https://pubmed.ncbi.nlm.nih.gov/19149499"},"language":"en","primary_location":{"id":"doi:10.2174/157488409787236047","doi":"https://doi.org/10.2174/157488409787236047","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157488409787236047","pdf_url":null,"source":{"id":"https://openalex.org/S165219199","display_name":"Current Clinical Pharmacology","issn_l":"1574-8847","issn":["1574-8847","2212-3938","2772-4328","2772-4336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-20","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027371881","display_name":"Jan Hendrik Beumer","orcid":"https://orcid.org/0000-0002-8978-9401","observed_orcids":["https://orcid.org/0000-0002-8978-9401"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan Beumer","raw_affiliation_strings":["Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands. beumerjh@upmc.edu","Department of Pharmacy and Pharmacology, Slotervaart Hospital\u2014The Netherlands Cancer Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands. beumerjh@upmc.edu","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital\u2014The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018880888","display_name":"Luis L\u00f3pez L\u00e1zaro","orcid":"https://orcid.org/0000-0003-0620-6133","observed_orcids":["https://orcid.org/0000-0003-0620-6133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Lopez-Lazaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Schellens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos Beijnen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034151807","display_name":"Olaf van Tellingen","orcid":"https://orcid.org/0000-0002-1037-6269","observed_orcids":["https://orcid.org/0000-0002-1037-6269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olaf Tellingen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.625,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.62951141,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"4","issue":"1","first_page":"38","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trabectedin","display_name":"trabectedin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/unbound-fraction","display_name":"unbound fraction","score":0.6729999780654907},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.800000011920929},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7039999961853027},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.7879999876022339},{"id":"https://openalex.org/keywords/ultrafiltration","display_name":"ultrafiltration","score":0.7179999947547913},{"id":"https://openalex.org/keywords/hepatic-extraction","display_name":"hepatic extraction","score":0.7080000042915344},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.9610445499420166},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6168276071548462},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.5840964913368225},{"id":"https://openalex.org/C146543888","wikidata":"https://www.wikidata.org/wiki/Q425056","display_name":"Blood proteins","level":2,"score":0.5599168539047241},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5509397983551025},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4724198579788208},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4537144899368286},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.4294455051422119},{"id":"https://openalex.org/C2778597219","wikidata":"https://www.wikidata.org/wiki/Q11721976","display_name":"Human serum albumin","level":2,"score":0.41545459628105164},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.4109508991241455},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34266218543052673},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2774502635002136},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.26922523975372314},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20167037844657898},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.2010800838470459},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09793585538864136}],"mesh":[{"descriptor_ui":"D000077606","descriptor_name":"Trabectedin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014462","descriptor_name":"Ultrafiltration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/157488409787236047","doi":"https://doi.org/10.2174/157488409787236047","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157488409787236047","pdf_url":null,"source":{"id":"https://openalex.org/S165219199","display_name":"Current Clinical Pharmacology","issn_l":"1574-8847","issn":["1574-8847","2212-3938","2772-4328","2772-4336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-20","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:19149499","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19149499","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320332713","display_name":"Cancer Institute, University of Pittsburgh","ror":"https://ror.org/01an3r305"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2060096874","https://openalex.org/W1964822853","https://openalex.org/W2002560602","https://openalex.org/W2968949497","https://openalex.org/W2601047108","https://openalex.org/W2027753970","https://openalex.org/W4240179300","https://openalex.org/W1859165359","https://openalex.org/W2411211918","https://openalex.org/W2022246505"],"abstract_inverted_index":{"Trabectedin":[0],"(ET-743,":[1],"Yondelis)":[2],"is":[3,145],"a":[4,16,25,42,68,74,158],"novel":[5],"anticancer":[6],"drug":[7],"with":[8,15,73],"impressive":[9],"activity":[10],"in":[11,152,175,182],"soft":[12],"tissue":[13],"sarcoma":[14],"manageable,":[17],"non-cumulative":[18],"toxicity":[19],"profile.":[20],"Protein":[21],"binding":[22,47,64,129,167,205],"can":[23,190],"be":[24,91],"major":[26,159],"determinant":[27],"of":[28,32,41,48,65,76,87,96,130,138,174,185],"unbound":[29,88,153],"concentration,":[30],"volume":[31],"distribution,":[33],"renal":[34],"and":[35,38],"hepatic":[36,148],"clearance,":[37],"the":[39,60,85,172,183,193],"half-life":[40],"drug.":[43],"Human":[44],"plasma":[45,62,115,207],"protein":[46,63,116,128,166,187],"trabectedin":[49,66,89,112,121,144,204],"has":[50],"not":[51,110,156],"previously":[52],"been":[53],"reported.":[54],"Using":[55],"ultrafiltration":[56],"techniques,":[57],"we":[58],"determined":[59],"human":[61],"at":[67,102,209],"clinically":[69,200],"relevant":[70,201],"concentration.":[71],"Experiments":[72],"panel":[75],"co-medications":[77,195],"representing":[78],"all":[79],"known":[80],"protein-binding":[81],"sites":[82],"showed":[83],"that":[84,120,192],"concentration":[86],"could":[90],"increased":[92],"by":[93],"high":[94,165],"concentrations":[95,103],"phenytoin.":[97],"The":[98,164],"other":[99],"tested":[100],"co-medications,":[101],"covering":[104],"their":[105],"respective":[106],"therapeutic":[107,210],"ranges,":[108],"did":[109],"displace":[111],"from":[113],"its":[114],"binding.":[117],"This":[118],"suggests":[119],"binds":[122],"to":[123,198,206],"albumin":[124],"site":[125],"I":[126],"(total":[127],"94.2":[131],"+/-0.6":[132],"%)":[133],"displaying":[134],"an":[135,146],"association":[136],"constant":[137],"2.6":[139],"+/-0.2":[140],"10(4)":[141],"M(-1).":[142],"Because":[143],"intermediate-to-high":[147],"extraction":[149],"drug,":[150],"changes":[151],"fraction":[154],"will":[155],"have":[157,169,199],"impact":[160],"on":[161,203],"elimination":[162],"processes.":[163],"may":[168],"implications":[170],"for":[171],"interpretation":[173],"vitro":[176],"data,":[177],"which":[178],"are":[179,196],"usually":[180],"performed":[181],"presence":[184],"low":[186],"levels.":[188],"We":[189],"conclude":[191],"studied":[194],"unlikely":[197],"effects":[202],"proteins":[208],"concentrations.":[211]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}